Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Vonopzan vs Vocinti in Healthy Subjects
NCT06642987Phase 1Completed
- Sponsor
- Hanlim Pharm
- Start
- Oct 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vonoprazan in gastric ulcer (2 arms), sponsored by Hanlim Pharm. Primary endpoints: Peak Plasma Concentration at 36 hours and Area under the plasma concentration versus time curve at 36 hours. Started Oct 2023; status: completed.
02
Drugs
vonoprazan
03
Conditions
gastric ulcer
Beyond the preview
Go deeper on NCT06642987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06642987.